C07K 2317/34
Identification of a linear epitope shorter than 20 amino acid residues or
Official title: Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
C07K2317/34 (Identification of a linear epitope shorter than 20 amino acid residues or) appears on 6,322 US grants and 10,156 published applications in this corpus.
Search patents in C07K- Granted patents
- 6,322
- Published applications
- 10,156
- Assignees
- 2,753
- Inventors
- 15,107
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 15 | 0 |
| 1994 | 18 | 0 |
| 1995 | 20 | 0 |
| 1996 | 22 | 0 |
| 1997 | 55 | 0 |
| 1998 | 62 | 0 |
| 1999 | 68 | 0 |
| 2000 | 57 | 0 |
| 2001 | 44 | 9 |
| 2002 | 39 | 82 |
| 2003 | 41 | 148 |
| 2004 | 49 | 141 |
| 2005 | 44 | 174 |
| 2006 | 64 | 172 |
| 2007 | 79 | 189 |
| 2008 | 76 | 198 |
| 2009 | 118 | 329 |
| 2010 | 132 | 283 |
| 2011 | 183 | 356 |
| 2012 | 201 | 394 |
| 2013 | 228 | 415 |
| 2014 | 263 | 493 |
| 2015 | 361 | 499 |
| 2016 | 362 | 602 |
| 2017 | 411 | 653 |
| 2018 | 427 | 583 |
| 2019 | 449 | 613 |
| 2020 | 418 | 607 |
| 2021 | 380 | 650 |
| 2022 | 392 | 630 |
| 2023 | 309 | 574 |
| 2024 | 357 | 563 |
| 2025 | 350 | 484 |
| 2026 | 210 | 315 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-MS4A4A antibodies and methods of use thereof6 Oct 2026US 12,753,225 B2Alector LLC
- Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders29 Sep 2026US 12,747,277 B2AvenCell Europe GmbH
- Compositions and methods related to human neutralizing antibodies to hepatitis B29 Sep 2026US 12,747,283 B2The Rockefeller University
- Means for specifically eliminating perilipin-1 fragment presenting adipocytes29 Sep 2026US 12,747,286 B2Alytas Therapeutics GmbH
- Tau-binding antibodies29 Sep 2026US 12,747,288 B2Ucb Biopharma Srl
- Agents that bind to cd16a and uses thereof8 Oct 2026US 2026/0308258 A1Avantgen, Inc.
- Compositions and methods for detection of aberrant cdk5 expression8 Oct 2026US 2026/0309712 A1Arizona Board of Regents on Behalf of the University of Arizona
- Car-t cell compositions, methods of use thereof1 Oct 2026US 2026/0297160 A1Augusta University Research Institute, Inc.
- Anti-allergen antibodies and uses thereof1 Oct 2026US 2026/0297169 A1
- Anti il-11 antibody1 Oct 2026US 2026/0297176 A1
Most cited
By later US patents
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999
- Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells512US 6,352,694 B1Genetics Institute, Inc. · 2002
- Optimized Fc variants463US 7,317,091 B2Xencor, Inc. · 2008
- Methods of treating HIV infected subjects386US 6,905,680 B2Genetics Institute, Inc. · 2005